The Primavera study protocol design: evaluating the effect of continuous erythropoiesis receptor activator (C.E.R.A.) on renal function in non-anemic patients with chronic kidney disease.
about
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysisSubcutaneous C.E.R.A. for the Treatment of Chronic Renal Anemia in Predialysis PatientsQuantitative assessment of minimal effective concentration of erythropoiesis-stimulating agents.Methoxy polyethylene glycol-epoetin beta for the treatment of anemia associated with chronic renal failure.Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease.Treatment of renal anemia: Erythropoiesis stimulating agents and beyond.Early low-dose erythropoiesis-stimulating agent therapy and progression of moderate chronic kidney disease: a randomized, placebo-controlled trial.
P2860
Q24187413-C976D542-354E-4781-A7F9-A7EFC00E19EFQ36983722-93A200C5-1D08-47A4-A9F3-C4C536B2A185Q37308372-D34E096B-162F-466D-97A0-10E9EB50D963Q38634832-7C76759D-FAE2-49AE-A87E-0D912682331BQ38637669-567461AE-B7D7-4FD7-B7FF-907AE4B6A6A2Q41387413-77A6C7BF-8E1F-435A-ABC8-3D6DD7306EA8Q51331304-6B5C75D4-20D7-40BA-A197-6861004C2375
P2860
The Primavera study protocol design: evaluating the effect of continuous erythropoiesis receptor activator (C.E.R.A.) on renal function in non-anemic patients with chronic kidney disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The Primavera study protocol d ...... s with chronic kidney disease.
@en
The Primavera study protocol d ...... thropoiesis receptor activator
@nl
type
label
The Primavera study protocol d ...... s with chronic kidney disease.
@en
The Primavera study protocol d ...... thropoiesis receptor activator
@nl
prefLabel
The Primavera study protocol d ...... s with chronic kidney disease.
@en
The Primavera study protocol d ...... thropoiesis receptor activator
@nl
P2093
P1476
The Primavera study protocol d ...... s with chronic kidney disease.
@en
P2093
P304
P356
10.1016/J.CCT.2011.06.008
P407
P577
2011-07-07T00:00:00Z